Merck (UKEX:MRK) Common Stock : ₴71,799 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Merck Common Stock?

Merck's quarterly common stock stayed the same from Sep. 2023 (₴71,799 Mil) to Dec. 2023 (₴71,799 Mil) and stayed the same from Dec. 2023 (₴71,799 Mil) to Mar. 2024 (₴71,799 Mil).

Merck's annual common stock stayed the same from Dec. 2021 (₴71,799 Mil) to Dec. 2022 (₴71,799 Mil) and stayed the same from Dec. 2022 (₴71,799 Mil) to Dec. 2023 (₴71,799 Mil).

Merck Common Stock Historical Data

The historical data trend for Merck's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Common Stock Chart

Merck Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

71,799.18

Merck Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Common Stock	Get a 7-Day Free Trial															71,799.18	71,799.18	71,799.18	71,799.18	71,799.18

Merck Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Merck (UKEX:MRK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (UKEX:MRK) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

MRK:USA MRK:Peru MRK:Mexico 1MRKX:Italy 6MKd:UK 0QAH:UK 6MK:Germany MRK:Chile MRCK34:Brazil MRK:Austria MRK:Argentina

Address

126 East Lincoln Avenue, Rahway, NJ, USA, 07065

Website

https://www.merck.com

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.